LI, PENG,ZHENG, HAILIN,ZHAO, JUN,WENNOGLE, LAWRENCE
申请号：
CA2961212
公开号：
CA2961212A1
申请日:
2015.09.17
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The subject matter generally relates to compounds and methods of treatment and/or prophylaxis of CNS diseases, disorders, and/or injuries. In one aspect, the subject matter relates to inhibitors of phosphodiesterase 1 (PDE1) as neuroprotective agents and/or neural regenerative agents. In a further aspect, the subject matter relates to individuals that are at risk for the development of CNS disease or disorder.
